These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 3097384
21. Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes. Scheen AJ, Jaminet C, Luyckx AS, Lefebvre PJ. Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):70-6. PubMed ID: 3104218 [Abstract] [Full Text] [Related]
22. How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes? Jeng CY, Hollenbeck CB, Wu MS, Chen YD, Reaven GM. Diabet Med; 1989 Feb; 6(4):303-8. PubMed ID: 2524334 [Abstract] [Full Text] [Related]
23. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide. Massi-Benedetti M, Herz M, Pfeiffer C. Horm Metab Res; 1996 Sep; 28(9):451-5. PubMed ID: 8911982 [Abstract] [Full Text] [Related]
24. Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man. Ligtenberg JJ, Venker CE, Sluiter WJ, Reitsma WD, Van Haeften TW. Eur J Clin Invest; 1997 Aug; 27(8):685-9. PubMed ID: 9279533 [Abstract] [Full Text] [Related]
28. [Effectiveness of combined treatment with glibenclamide and insulin in secondary sulfonylurea failure. A controlled multicenter double-blind clinical trial]. Bachmann W, Lotz N, Mehnert H, Rosak C, Schöffling K. Dtsch Med Wochenschr; 1988 Apr 22; 113(16):631-6. PubMed ID: 3129273 [Abstract] [Full Text] [Related]
29. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus. Garvey WT, Revers RR, Kolterman OG, Rubenstein AH, Olefsky JM. J Clin Endocrinol Metab; 1985 Mar 22; 60(3):559-68. PubMed ID: 3882736 [Abstract] [Full Text] [Related]
31. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man. Raptis SA, Hatziagelaki E, Dimitriadis G, Draeger KE, Pfeiffer C, Raptis AE. Exp Clin Endocrinol Diabetes; 1999 Mar 22; 107(6):350-5. PubMed ID: 10543411 [Abstract] [Full Text] [Related]
37. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone. Groop L, Harno K, Nikkilä EA, Pelkonen R, Tolppanen EM. Acta Med Scand; 1985 Mar 22; 217(1):33-9. PubMed ID: 3919531 [Abstract] [Full Text] [Related]
38. The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes. Groop L, Harno K, Tolppanen EM. Acta Endocrinol (Copenh); 1984 May 22; 106(1):97-101. PubMed ID: 6428120 [Abstract] [Full Text] [Related]
40. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea. Gutniak M, Karlander SG, Efendić S. Diabetes Care; 1987 May 22; 10(5):545-54. PubMed ID: 2890501 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]